JPS63218676A - Azabicyclo compound and its manufacturing method - Google Patents
Azabicyclo compound and its manufacturing methodInfo
- Publication number
- JPS63218676A JPS63218676A JP5268487A JP5268487A JPS63218676A JP S63218676 A JPS63218676 A JP S63218676A JP 5268487 A JP5268487 A JP 5268487A JP 5268487 A JP5268487 A JP 5268487A JP S63218676 A JPS63218676 A JP S63218676A
- Authority
- JP
- Japan
- Prior art keywords
- azabicyclo
- alkoxycarbonyl
- formula
- compound
- bis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 7
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005977 Ethylene Substances 0.000 claims abstract description 5
- ILPBINAXDRFYPL-UHFFFAOYSA-N 2-octene Chemical compound CCCCCC=CC ILPBINAXDRFYPL-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910000497 Amalgam Inorganic materials 0.000 claims abstract description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 4
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims description 7
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003905 agrochemical Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 abstract description 2
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 abstract description 2
- XLRPYZSEQKXZAA-OCAPTIKFSA-N tropane Chemical compound C1CC[C@H]2CC[C@@H]1N2C XLRPYZSEQKXZAA-OCAPTIKFSA-N 0.000 abstract description 2
- 229930004006 tropane Natural products 0.000 abstract description 2
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 abstract description 2
- LCQRWOSXDVUZGG-UHFFFAOYSA-N 8-methyl-8-azabicyclo[3.2.1]octa-3,6-diene Chemical compound C1C=CC2C=CC1N2C LCQRWOSXDVUZGG-UHFFFAOYSA-N 0.000 abstract 1
- 238000007259 addition reaction Methods 0.000 abstract 1
- 229940088623 biologically active substance Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- XQJMXPAEFMWDOZ-BTTYYORXSA-N tropacocaine Chemical compound O([C@@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-BTTYYORXSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- -1 heptoxycarbonyl Chemical group 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- YLSCXJBLUJOMDE-UHFFFAOYSA-N octa-2,6-diene Chemical compound [CH2]C=CCCC=CC YLSCXJBLUJOMDE-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- FTHKWIMQNXVEHW-UHFFFAOYSA-N 1-ethynylsulfonyl-4-methylbenzene Chemical group CC1=CC=C(S(=O)(=O)C#C)C=C1 FTHKWIMQNXVEHW-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HJGMRAKQWLKWMH-UHFFFAOYSA-N 8-methyl-8-azabicyclo[3.2.1]octan-3-amine Chemical compound C1C(N)CC2CCC1N2C HJGMRAKQWLKWMH-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 101100428830 Caenorhabditis elegans mml-1 gene Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 102100035591 POU domain, class 2, transcription factor 2 Human genes 0.000 description 1
- 101710084411 POU domain, class 2, transcription factor 2 Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- MJGFBOZCAJSGQW-UHFFFAOYSA-N mercury sodium Chemical compound [Na].[Hg] MJGFBOZCAJSGQW-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001023 sodium amalgam Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は、医°薬、農薬の中間体等として有用な(式中
、Eはアルコキシカルボニル基を表す、)で示されるア
ザビシクロ化合物およびその製造方法に関する。Detailed Description of the Invention <Industrial Application Field> The present invention relates to an azabicyclo compound represented by the formula (wherein E represents an alkoxycarbonyl group) useful as an intermediate for pharmaceuticals, agricultural chemicals, etc. Regarding the manufacturing method.
〈従来の技術、発明が解決しようとする問題点〉上記一
般式〔!〕で示されるアザビシクロ化合物は文献未記載
の化1合物である。またその製造方法については以下の
方法が考えられる。<Prior art and problems to be solved by the invention> The above general formula [! The azabicyclo compound represented by ] is a compound of Compound 1 that has not been described in any literature. Further, the following methods can be considered as the manufacturing method.
例えば■既知化合、物8−アルコキシカルボニル−8−
アザビシクロ(3,2,1)オクタン−3−オン(J
、11++、’Ches+、 So’c、、 96.3
336 (1974) )のトシルヒドラゾンをメチル
リチウムで処理する方法。For example, ■Known compound, compound 8-alkoxycarbonyl-8-
Azabicyclo(3,2,1)octan-3-one (J
, 11++, 'Ches+, So'c,, 96.3
336 (1974)) by treating tosylhydrazone with methyllithium.
■2−アルコキシカルボニルー2−アザビシクロ(3,
1,O)ヘキセン−3にトシルアセチレンを付加させる
ことにより、得られることが予想される文献未記載の8
−アルコキシカルボニル−6(あるいは7)−トシル−
8−アザビシクロ(3,2,1)オクタ−2,s−7エ
ンのトシル基を除去する方法。■2-Alkoxycarbonyl-2-azabicyclo(3,
1,O) By adding tosylacetylene to hexene-3, 8, which is not described in the literature, is expected to be obtained.
-Alkoxycarbonyl-6 (or 7)-tosyl-
A method for removing the tosyl group of 8-azabicyclo(3,2,1)oct-2,s-7ene.
■既知物質2.6.7− トリ(アルコキシカルボニル
)−8−アザビシクロ(3,2,1)オクタ−2,6−
ジエン(J、 Org、Ches、、 39.2715
(1974) )を加水分解して得られる6、7−ジカ
ルボン酸をキノリン中、銅粉と共に加熱し脱炭酸する方
法などである。■Known substance 2.6.7- Tri(alkoxycarbonyl)-8-azabicyclo(3,2,1)octa-2,6-
Diene (J, Org, Ches, 39.2715
(1974))) is decarboxylated by heating the 6,7-dicarboxylic acid obtained by hydrolyzing it with copper powder in quinoline.
しかしながら、これらの方法を実際に検討したところ、
■、■の方法では目的物が全く検出されず、また■の方
法では前駆体である付加体が得られなかった。However, when we actually examined these methods, we found that
In methods (1) and (2), the target product was not detected at all, and in method (2), no adduct, which was a precursor, was obtained.
〈問題点を解決するための手段〉
本発明者らは、−a式(1)で示されるアザビシクロ°
化合物すなわち8−アルコキシカルボニル−8−アザビ
シクロ(3,2,1)オクタ−2,6−ジエンの製法に
ついて種々検討を重ねた結果、次式で示される製造ルー
トを見出すとともに該化合物は医農薬の中間体等として
有用であることを見出(II) (m)
(IV)すなわち本発明は
(式中、Eはアルコキシカルボニル基を表す、)で示さ
れるアザビシクロ化合物および
(2)2−アルコキシカルボニル−2−アザビシクロ(
3,1,0)ヘキセン−3〔■〕にビス(アリールスル
フォニル)エチレン(III)ヲ付加させ、8−アルコ
キシカルボニル−6,7−ビス(アリールスルフォニル
)−8−アザビシクロ(3,2,1)オフ \テ、ンー
2〔■〕を得る第1工程、および(IV)にアルカリ金
属アマルガムを作用させてアリールスルフォニル基を脱
離させる第2工程よりなることを特徴とする一般式(■
〕で示されるアザビシクロ化合物の製造方法を提供する
ものである。<Means for solving the problem> The present inventors have discovered that the azabicyclo °
As a result of various studies on the production method of the compound, 8-alkoxycarbonyl-8-azabicyclo(3,2,1)octa-2,6-diene, we found the production route shown by the following formula, and the compound is suitable for pharmaceutical and agricultural purposes. Found to be useful as an intermediate etc. (II) (m)
(IV) That is, the present invention provides an azabicyclo compound represented by (wherein E represents an alkoxycarbonyl group) and (2) 2-alkoxycarbonyl-2-azabicyclo (
3,1,0) Hexene-3 [■] is added with bis(arylsulfonyl)ethylene (III) to form 8-alkoxycarbonyl-6,7-bis(arylsulfonyl)-8-azabicyclo(3,2,1 ) off \te, -2 [■], and a second step of treating (IV) with an alkali metal amalgam to eliminate the arylsulfonyl group.
The present invention provides a method for producing an azabicyclo compound shown in the following.
本発明のアザビシクロ化合物(I)はアルコキシカル・
ボニル基を有するが、かかる置換基としては、例えば、
メトキシカルボニル、エトキシカルボニル、プロポキシ
カルボニル、ブトキシカルボニル、ペントキシカルボニ
ル、ヘプトキシカルボニルなどの低級アルコキシカルボ
ニルが゛挙げられる。The azabicyclo compound (I) of the present invention is an alkoxylic
It has a bonyl group, and such substituents include, for example,
Examples include lower alkoxycarbonyl such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, butoxycarbonyl, pentoxycarbonyl, and heptoxycarbonyl.
次に本発明の方法について説明する。Next, the method of the present invention will be explained.
本発明方法の出発原料である2−アルコキシカルボニル
−2−アザビシクロ(3,1,0)ヘキセン−3(II
)G*N−アルコキシカルボニルビロールにジアゾメタ
ンを反応させて製造することができる(例えばJ 、
CheIl、Soc、、457(196’1))−ここ
でアルコキシカルボニル基としては前記一般式(1)と
同様の置換基が挙げられる。2-alkoxycarbonyl-2-azabicyclo(3,1,0)hexene-3(II) which is the starting material for the process of the present invention
) can be produced by reacting G*N-alkoxycarbonylpyrrole with diazomethane (for example, J,
CheIl, Soc, 457(196'1)) - Here, examples of the alkoxycarbonyl group include the same substituents as in the above general formula (1).
モラ一方の原料はビス(アリールスルフォニル)エチレ
ン(Ill)であるが、アリール基としては、例えばフ
ェニル、トリル、キシリル等が挙げられる。またシス体
、トランス体いずれの異性体でも、またこれ等の混合物
でも使用できる。One of the raw materials is bis(arylsulfonyl)ethylene (Ill), and examples of the aryl group include phenyl, tolyl, xylyl, and the like. Furthermore, either the cis isomer or the trans isomer or a mixture thereof can be used.
上記化合物(n)、(III)を反応せしめて化合物(
IV)を得る第1工程を実施するに当たっては単に化合
物〔■°〕、(1113を混合し加熱するだけで十分で
ある0反応温度は通常80〜120°C1両化合物のモ
ル比は通常t:O,a〜o、s:iの範囲であり、反応
時間は2.5〜3.5時間が一般的である。The above compounds (n) and (III) are reacted to form a compound (
In carrying out the first step to obtain IV), it is sufficient to simply mix and heat the compound [■°], (1113).The reaction temperature is usually 80 to 120°C.The molar ratio of both compounds is usually t: The range is O, a to o, s:i, and the reaction time is generally 2.5 to 3.5 hours.
生成した化合物[IV]は適当な方法、例えば再結晶に
より精製する°こともできる。The produced compound [IV] can also be purified by an appropriate method, such as recrystallization.
また第2工程であるスルフォニル基の脱離反応はナトリ
ウム、リチウムなどのアルカリ金属アマルガムの作用に
よって進行する。その使用量は基質に対して、通常2〜
lO当量である。リン酸二水素ナトリウムなどのpH3
II剤の存在下に行えば反応は円滑に進行する0反応溶
媒は通常メタノールエタノールなどの低級アルコールが
用いられる。Further, the second step, the elimination reaction of the sulfonyl group, proceeds under the action of an alkali metal amalgam such as sodium or lithium. The amount used is usually 2 to 2
1O equivalent. pH 3 such as sodium dihydrogen phosphate
The reaction proceeds smoothly if carried out in the presence of agent II. Lower alcohols such as methanol and ethanol are usually used as the reaction solvent.
反応は室温でも容易に進行し、通常5〜15時間で完結
する。目的物は蒸留、再結晶、カラムクロマト、液体ク
ロマト等により精製することもできる〈発明の効果〉
一般式(1)で示される本発明の化合物は、例えば医農
薬等の生理活性物質あるいはその製造中間体とし゛て有
用である0例えば、本発明の化合物は8−メチル−8−
アザビシクロ(3,2,1)オクタ−2,6ジエンなど
の文献未記載の化合物へ誘導することができ、さらにこ
れらの化合物を経由してトロパン、トロピン、トロパコ
カイン等の既知の生理活性物質へ誘導することもできる
。The reaction proceeds easily even at room temperature and is usually completed in 5 to 15 hours. The target product can also be purified by distillation, recrystallization, column chromatography, liquid chromatography, etc. <Effects of the Invention> The compound of the present invention represented by general formula (1) can be used for bioactive substances such as pharmaceuticals and agricultural chemicals or for the production thereof. For example, compounds of the present invention are useful as 8-methyl-8-
Can be induced into compounds not described in literature such as azabicyclo(3,2,1)octa-2,6 diene, and further induced into known physiologically active substances such as tropane, tropine, and tropacacocaine via these compounds. You can also.
また本発明の方法によれば上述のような種々の用途を有
する化合物を効率よく製造し得る。Further, according to the method of the present invention, compounds having various uses as described above can be efficiently produced.
〈実施例〉
以下、実施例により本発明の詳細な説明するが、本発明
は実施例のみに限定されるものではない。<Examples> Hereinafter, the present invention will be explained in detail with reference to Examples, but the present invention is not limited only to the Examples.
、 実施例1
(1−1) 8−メトキシカルボニル−6,7−ビス
(フェニルスルホニル)−8−7ザビシクロ〔3゜2.
1〕オクテン−2の製造
2−メトキシカルボニル−2〜7ザビシクロ(3,1,
0)ヘキセン−3480−g (3,45mmol)と
シス−ビス(フェニルスルホニル)エチレンi、06g
(3,45mmol )との混合物を100”Cで3.
5時間加熱した。, Example 1 (1-1) 8-methoxycarbonyl-6,7-bis(phenylsulfonyl)-8-7zabicyclo[3°2.
1] Production of octene-2 2-methoxycarbonyl-2-7zabicyclo(3,1,
0) Hexene-3480-g (3,45 mmol) and cis-bis(phenylsulfonyl)ethylene i, 06 g
(3.45 mmol) at 100"C.
Heated for 5 hours.
放冷後、得られる黄色固体をクロロホルムより再結晶し
、目的物1.14 g (2,55mmol ) ヲ得
り。After cooling, the resulting yellow solid was recrystallized from chloroform to obtain 1.14 g (2.55 mmol) of the desired product.
収率フ4%、無色結晶 融点268〜270″C(分解
)。Yield 4%, colorless crystals, melting point 268-270''C (decomposed).
元素分析(Cm+Hg+NJSt)
HNS
計算値(%) 56,36 4.73 3.13 1
4.33実測I(%) 56.58 4.[io
2.88 14.45マス分析(13,5eV1.10
0 ”C)m/e 306 (M” −5o、Ph、b
ase) 、165 (58%)I R(KBr)
1700.1340,1310.1155,690.6
00 am−’’H−NMR(90MIIz 、δ、
、、)1.03−1.48(IH,s)、2.30−2
.62 (III、d、J諺1B、OH,)3.63
(3H,S)、4.10(2)1.*)、4.62−4
.80(2B、鳳)。Elemental analysis (Cm+Hg+NJSt) HNS Calculated value (%) 56,36 4.73 3.13 1
4.33 Actual measurement I (%) 56.58 4. [io
2.88 14.45 mass analysis (13,5eV1.10
0 "C) m/e 306 (M" -5o, Ph, b
ase), 165 (58%) I R (KBr) 1700.1340, 1310.1155, 690.6
00 am-''H-NMR (90 MIIz, δ,
,,)1.03-1.48(IH,s),2.30-2
.. 62 (III, d, J proverb 1B, OH,) 3.63
(3H,S), 4.10(2)1. *), 4.62-4
.. 80 (2B, Otori).
5.38−5.62(ill、d、J=9.5 H,
)。5.38-5.62 (ill, d, J=9.5 H,
).
5.62−5.85(II(、d、J震9.5 II
、)。5.62-5.85 (II (, d, J earthquake 9.5 II
,).
7.37−7.80(611,m)、7.80−8.0
6(411,5)(1−2) 8−メトキシカルボニ
ル−8−アザビシクロ(3,2,1)オクタ2.6−ジ
エンの製造(1−1)の方法で得たジフェニルスルホニ
ル化合物2.29g (5,12mmol)とリン酸二
水素ナトリウムニ水和物13.7 gを125mのメタ
ノールに溶解し、30分間窒素ガスを吹き込んだ。7.37-7.80 (611, m), 7.80-8.0
6(411,5)(1-2) 2.29 g of diphenylsulfonyl compound obtained by the method for producing 8-methoxycarbonyl-8-azabicyclo(3,2,1)octa2,6-diene (1-1) (5.12 mmol) and 13.7 g of sodium dihydrogen phosphate dihydrate were dissolved in 125 m of methanol, and nitrogen gas was blown into the solution for 30 minutes.
これにナトリウムアマルガム(1,5%)62g(8当
量)を加え室温で9時間撹拌した後、生成した水銀と不
溶物を濾別し、n−へキサンで抽出した(50mX 2
) 、 n−ヘキサン層を無水硫酸ナトリウムで乾燥
後、減圧下に溶媒を留去して、無色油状物782mgを
得た。この油状物は目的物と8−メトキシカルボニル−
8−アザビシクロ(3,2,1)オクトテン−2の混合
物(19:1)であった。After adding 62 g (8 equivalents) of sodium amalgam (1.5%) to this and stirring at room temperature for 9 hours, the generated mercury and insoluble matter were filtered off and extracted with n-hexane (50 m
After drying the n-hexane layer over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure to obtain 782 mg of a colorless oil. This oily substance is the target product and 8-methoxycarbonyl-
It was a mixture of 8-azabicyclo(3,2,1)octene-2 (19:1).
・ この油状物から、中圧液体り・口尋ト(1,25
%酢酸エチル/n−ヘキサン)により、目的物612m
gを分離した。・ From this oily substance, pour medium pressure liquid and mouthwash (1,25
% ethyl acetate/n-hexane), the target product 612m
g was separated.
収率72.3%、無色油状、沸点90 ”C(1,5m
m1g)元素分析(C*Il++NO冨)
HN
計算値(%) 65,44 6.71 8.48実測
値(%) 65,15 6.92 8.60マス分析
(13,5eV、 80″C)m/e I65 (
M+ 、base) +150(19%ン、161
(31%)I R(oil)
1700、1445.13&0.1290.1405c
m−’’II−NMR(90M11 友 、 et
’:?二 >1.76 (111,ddd、J=Il1
1.3. 2.0. 3.7 ++* )。Yield 72.3%, colorless oil, boiling point 90"C (1.5m
m1g) Elemental analysis (C*Il++NO-rich) HN Calculated value (%) 65,44 6.71 8.48 Actual value (%) 65,15 6.92 8.60 Mass analysis (13,5eV, 80″C) m/e I65 (
M+, base) +150 (19%, 161
(31%) I R (oil) 1700, 1445.13 & 0.1290.1405c
m-''II-NMR (90M11 friend, et
':? 2 >1.76 (111, ddd, J=Il1
1.3. 2.0. 3.7 ++*).
2.73(LH,d、J、18.3n、)。2.73 (LH, d, J, 18.3n,).
3.69(38,s)、4.50 (Ill、霧、Js
2.3 Rm )。3.69 (38,s), 4.50 (Ill, fog, Js
2.3 Rm).
4.62(IH,m、J−2,’7H*)+5.29(
IH,m、J−9,411m)+5.87(LH,dd
、J寓6.0.2,311.)。4.62(IH,m,J-2,'7H*)+5.29(
IH, m, J-9,411m) + 5.87 (LH, dd
, J Fable 6.0.2, 311. ).
6.12(1’11.m、J−9,411、)。6.12 (1'11.m, J-9,411,).
6.40(LH,dd、J=6.0.2.3+1.)U
V (cyclohexane) λ (g
°)=218(610)n+m参考例1
8−メチル−8−アザビシクロ(3,2,1)オクタ−
2,6−ジエンの製造
実施例1−2で得た8−メトキシカルボニル誘導体31
2mg(1,89mmol)を無水エーテル1011に
溶解し、これをリチウムアルミニウムハイドライド20
0mg(5,27mmol )を含む無水エーテル懸濁
液50ifに室温下で滴下し、さらに30分間加熱還流
した。 放冷後、酢酸エチル101dを徐々に加え、過
剰の還元試薬を分解し、不溶物を濾別した。得られた育
機層を減圧下に濃縮して無色油軟物226s*qを得た
0次いで減圧蒸留を行い目的物221mgを得た。6.40 (LH, dd, J=6.0.2.3+1.)U
V (cyclohexane) λ (g
°)=218(610)n+m Reference Example 1 8-Methyl-8-azabicyclo(3,2,1)octa-
8-Methoxycarbonyl derivative 31 obtained in Production Example 1-2 of 2,6-diene
2 mg (1,89 mmol) was dissolved in anhydrous ether 1011, and this was dissolved in lithium aluminum hydride 20
It was added dropwise to 50 if of an anhydrous ether suspension containing 0 mg (5.27 mmol) at room temperature, and the mixture was further heated under reflux for 30 minutes. After cooling, 101d of ethyl acetate was gradually added to decompose the excess reducing reagent, and insoluble matter was filtered off. The obtained growth layer was concentrated under reduced pressure to obtain 226 s*q of colorless oily substance.Next, vacuum distillation was performed to obtain 221 mg of the target product.
収率96.3%、沸点60℃(10mml1g)元素分
析(C@HIIN)
HN
計算値(%) 79,29 9.15 1r、56実
測値(%) 78.92 9.18 11.33マス
分析(’13.5eV、 80℃)m/e 121 (
M” 、base) +120(45%)、94
(73%)I R(oll)
2920.1438.1315.12B5.1105;
770c’m−’’ HNMR(90Mll富 *
6 ’pc’s )1.70 (Ill、
+w、J−18,3H,)、2.27(38,s)。Yield 96.3%, boiling point 60°C (10 mml 1 g) Elemental analysis (C@HIIN) HN Calculated value (%) 79,29 9.15 1r, 56 Actual value (%) 78.92 9.18 11.33 mass Analysis ('13.5eV, 80℃) m/e 121 (
M”, base) +120 (45%), 94
(73%) I R(oll) 2920.1438.1315.12B5.1105;
770c'm-'' HNMR (90Mll wealth *
6'pc's) 1.70 (Ill,
+w, J-18,3H,), 2.27 (38,s).
2.49 < 111.m、J−18,311,)、3
.45C2H,ei)。2.49 < 111. m, J-18,311,), 3
.. 45C2H, ei).
5.30 (IH冒、−8J・7.8.3.011
g)。5.30 (IH, -8J・7.8.3.011
g).
5.72(111,、dd、J・5.4.2.011.
)。5.72 (111,, dd, J.5.4.2.011.
).
5.80(111,dddd、J、7.8.5.3,1
.2.1.2.H,)。5.80 (111, dddd, J, 7.8.5.3, 1
.. 2.1.2. H,).
Claims (2)
れるアザビシクロ化合物。(1) Azabicyclo compound represented by the general formula ▲ Numerical formula, chemical formula, table, etc. ▼ (In the formula, E represents an alkoxycarbonyl group.)
3.1.0〕ヘキセン−3にビス(アリールスルフォニ
ル)エチレンを付加させ、8−アルコキシカルボニル−
6,7−ビス(アリールスルフォニル)−8−アザビシ
クロ〔3.2.1〕オクテン−2を製造する第1工程、
および該付加体にアルカリ金属アマルガムを作用させて
アリールスルフォニル基を脱離させる第2工程よりなる
ことを特徴とする一般式 ▲数式、化学式、表等があります▼ (式中、Eはアルコキシカルボニル基を表す。)で示さ
れるアザビシクロ化合物の製造方法。(2) 2-alkoxycarbonyl-2-azabicyclo [
3.1.0] Adding bis(arylsulfonyl)ethylene to hexene-3 to form 8-alkoxycarbonyl-
A first step of producing 6,7-bis(arylsulfonyl)-8-azabicyclo[3.2.1]octene-2,
and a second step in which the adduct is treated with an alkali metal amalgam to remove the arylsulfonyl group ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (where E is an alkoxycarbonyl group) A method for producing an azabicyclo compound represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5268487A JPS63218676A (en) | 1987-03-06 | 1987-03-06 | Azabicyclo compound and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5268487A JPS63218676A (en) | 1987-03-06 | 1987-03-06 | Azabicyclo compound and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63218676A true JPS63218676A (en) | 1988-09-12 |
Family
ID=12921713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5268487A Pending JPS63218676A (en) | 1987-03-06 | 1987-03-06 | Azabicyclo compound and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63218676A (en) |
-
1987
- 1987-03-06 JP JP5268487A patent/JPS63218676A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH052678B2 (en) | ||
JPS6122046A (en) | Stilbene derivative | |
US3651106A (en) | Preparation of 2-(6-methoxy-2-naphthyl)propionic acid -1-propanol and propanal and intermediates therefor | |
CA1325807C (en) | Tetracyclic antidepressants | |
JPH0393787A (en) | Pharmaceutical agent having viral action or antiviral action, phospholipid derivative and method of its preparation | |
JPS63218676A (en) | Azabicyclo compound and its manufacturing method | |
JPS6260A (en) | Production of cyclopentenylheptanoic acid | |
CS212221B2 (en) | Method of making the (+) 3a, 7a-trans-4-/7,7-/ethylenedioxy /-oxooktyl/-7a beta-methylperhydroindane-1,5-dion | |
JPH04261161A (en) | Fluoroalkyl group-containing pyrimidine derivative and production thereof | |
EP0319576B1 (en) | Prostaglandin derivatives, processes for preparing them and pharmaceutical compositions containing said derivatives | |
JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
JPS5940839B2 (en) | Method for producing mixed acid type 1,2-diacyl-3-glycerylphosphorylcholines | |
US3769364A (en) | Carboxyphenyl esters of propenyl and propadienylphosphonic acids | |
EP0164852A1 (en) | 1-(Substituted-aryl)-Dihydro-1H-pyrrolizine-3,5-(2H,6H-)diones, a process for producing the compounds and a pharmaceutical composition comprising the compounds | |
JPH01216965A (en) | Production of 2-alkoxypropionic acid amide derivative | |
JPS5921671A (en) | 2-methylbenzimidazole derivative and insecticide containing the same | |
JPS62286984A (en) | 3-phenylthio-2-(1'-hydroxy-1'-substituted-methyl)-4-pentanolide compound and production thereof | |
JPS601312B2 (en) | Novel imidazole derivative | |
JPH0967293A (en) | Production of 2,3-benzocycloaklenone | |
JPS62228049A (en) | 1-(cyanomethyl)fulvene compound and production thereof | |
JPS6368578A (en) | Production of 5-butyldihydro-4-methyl-2(3h)-furanone | |
JPS591452A (en) | Synthesis of 2-diethylamino-1-methylethyl- cis-1-hydroxy-(bicyclohexyl)-2-carboxylate derivatives and compounds thereby | |
JPH04257565A (en) | Polyfluoroalkyl group-containing pyrimidine derivative and its production | |
JPH01272559A (en) | 2,6-diethylaniline derivative and production thereof | |
JPS6323850A (en) | 3-cyanomethylene-4-alkylidene-1-cyclopentene derivative and production thereof |